SXTC - China SXT Pharmaceuticals Revenue Dynamics YoY (Last Twelve Months)

China SXT Pharmaceuticals specializes in the mass production of low-cost traditional medicines. Tracking the TTM revenue volatility compared to the same period last year on GURU.Markets, we note that the indicator value is -34.80. Diversified raw material import channels ensure operational resilience, yet a deficit in commercial revenue and R&D expenses create significant cash flow pressure, forcing the company to raise external capital.
China SXT Pharmaceuticals - analytical breakdowns and key metrics (SXTC)

Professional capital evaluates China SXT Pharmaceuticals (SXTC) through the lens of niche brand resilience within the volatile micro-cap segment of traditional medicine. By analyzing the rolling annual change in sales volume, investors determine the business's ability to pass inflationary costs onto consumers, where any downward trend signals margin compression and a decline in the asset's fundamental reliability.